Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification - A role in pathogenesis and antiproliferative chemotherapy

General Pharmacology

Volumn 27, Issue 4, 1996, Pages 565-573

  Thornalley, Paul J ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

Apoptosis; Glycation; Glyoxalase; Methylglyoxal

Indexed keywords

METHYLGLYOXAL;

AGING; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; DRUG DETOXIFICATION; DRUG EFFECT; DRUG MECHANISM; GENOTOXICITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STARVATION;

EID: 0030176306     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02054-3     Document Type: Review

References (77)

1. Allen R. E., Lo T. W. C. and Thornalley P. J. (1993) A simplified method for the purification of human red blood cell glyoxalase I. Characteristics, immunoblotting and inhibitor studies. J. Protein Chem. 12, 111-119.
2. Araki N., Higashi T., Mori T., Shibayama R., Kawabe Y., Kodama T., Takahashi T., Schichiri M. and Horiuchi S. (1995) Macrophage scavenger receptor mediates endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur. J. Biochem. 230, 408-415.
3. Ayoub F. M., Alien R. E. and Thornalley P. J. (1993) Inhibition of proliferation of human leukemia 60 cells by methylglyoxal in vitro. Leuk. Res. 17, 397-401.
4. Brambilla G., Sciaba L., Faggin P., Finollo R., Bassi A. M., Ferro M. and Marinari U. M. (1985) Methylglyoxal-induced DNA-protein crosslinks and cytotoxicity in Chinese hamster ovary cells. Carcinogenesis 6, 683-686.
5. Brownlee M., Vlassara H., Kooney A., Ulrich P. and Cerami A. (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232, 1629-1632.
6. Buttke T. M. and Sandstrom P. A. (1994) Oxidative stress as a mediator of apoptosis. Immunol. Today 15, 7-10.
7. Cameron N. E., Cotter M. A. and Love A. (1992) Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35, 946-950.
8. Cook P. N., Ward W. H. J., Petrash J. M., Mirrlees D. J., Sennitt C. M., Carey F., Preston J., Brittain D. R., Tuffin D. P. and Howe R. (1995) Kinetic characteristics of Zeneca ZD5522, a potent inhibitor of human and bovine lens aldose reductase. Biochem. Pharmacol. 49, 1043-1049.
9. Creighton D. J., Migliorini M., Pourmotabbed T. and Guha M. K. (1988) Optimization of efficiency in the glyoxalase pathway. Biochemistry 27, 7376-7384.
10. Diamond J. R., Ding G., Frye J. and Diamond I.-P. (1992) Glomerular macrophages and the mesangial proliferative response in experimental nephrotic syndrome. Amer. J. Pathol. 141, 887-894.
11. Dills W. L. (1993) Nutritional and physiological consequences of tumor glycolysis. Parasitology 107, S177-S186.
12. Espat N.J., Copeland E. M. and Moldawer L. L. (1994) Tumor-necrosis-factor and cachexia - a current perspective. Surgical Oncol. 3, 255-262.
13. Faggin P., Bassi A. M., Finollo R. and Brambilla G. (1985) Induction of sister-chromatid exchanges in Chinese hamster ovary cells by the biotic ketoaldehyde methlyglyoxal. Mut. Res. 144, 189-191.
14. Glomb M. A. and Monnier V. M. (1995) Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J. Biol. Chem. 276, 10017-10026.
15. Grimshaw C. E. (1992) Aldose reductase: model for a new paradigm of enzymic perfection in detoxification catalysts. Biochemistry, 31, 10139-10145.
16. Haik G., Jr., Lo T. W. C. and Thornalley P. J. (1994) Methylglyoxal concentration and glyoxalase activities in the human lens. Exp. Eye Res. 59, 497-500.
17. Hammes H.-P., Martin S., Federlin K., Geiser, K. and Brownlee M. (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. USA 88, 11555-11558.
18. Jerzykowski T., Matuszewski W., Tarnawski W., Herman Z. S. and Sokda A. (1975) Changes of certain pharmacological and biochemical indices in acute methylglyoxal poisoning. Arch. Immunol. Therap. Exp. 23, 549-560.
19. Kador P. F. (1988) The role of aldose reductase in the development of diabetic complications. Med. Res. Revs. 8, 325-352.
20. Rang Y., Edwards L. G. and Thomalley P. J. (1996) Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA, G, growth arrest and induction of apoptosis. Leuk. Res., in press.
21. Kasai H., Kumeno K., Yamaizumi Z., Nishimura S., Nagao M., Fujita Y., Sugimura T., Nukaya H. and Kosuge T. (1982) Mutagenicity of methylglyoxal in coffee. Gann 73, 681-683.
22. Koop D. R. and Casazza J. P. (1985) Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monoxygenase of rabbit microsomes. J. Biol. Chem. 260, 13607-13612.
23. Krymkiewicz N. (1973) Reactions of methylglyoxal with nucleic acids. FEBS Lett. 29, 51-54.
24. Larsen K., Aronsson A.-C., Marmstal E. and Mannervik B. (1985) Immunological comparison of glyoxalase I from yeast and mammals with quantitative determination of the enzyme in human tissues by radioimmunoassay. Comp. Biochem. Physiol. 82B, 625-638.
25. Limb G. A., Barley O., Jones S. E., Leroy F., Chignell A. H. and Dumonde D. C. (1994) Expression of messenger-RNA coding for TNF-alpha, IL-1beta and IL-6 by cells infiltrating retinal membranes. Graeffes Arch. Clin. Exp. Opthalmol. 232, 646-651.
26. Lo T. W. C. and Thornalley P. J. (1992) Inhibition of proliferation of human leukemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro. Biochem. Pharmacol. 44, 2357-2363.
27. α-acetyl-lysine, and bovine serum albumin. J. Biol. Chem. 269, 32299-32305.
28. Lo T. W. C., Selwood T. and Thornalley P. J. (1994b) The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem. Pharmacol. 48, 1865-1870.
29. Lovett D. H., Ryan J. L. and Sterzel R. B. (1983) Stimulation of rat mesangial cell proliferation by macrophage interleukin 1. J. Immunol. 131, 2830-2836.
30. Lubec G., Vierhapper H., Bailey A. J., Damjanic P., Fasching P., Sims T. J., Kampel D., Popow C. and Bartosch B. (1991) Influence of L-arginine on glucose-mediated collagen cross links precursors in patients with diabetes mellitus. Amino Acicis, 1, 73-80.
31. Lyles G. A. and Chalmers J. (1992) The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amino oxidase in human umbilical artery. Biochem. Pharmacol. 43, 1409-1414.
32. McCance D. R., Dyer D. G., Dunn J. A., Baillie K. E., Thorpe S. R., Baynes J. W. and Lyons T. J. (1993). Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 91, 2470-2478.
33. McLellan A. C., Phillips S. A. and Thornalley P. J. (1992) The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal. Biochem. 206, 17-23.
34. McLellan A. C., Thornalley P. J., Benn J. and Sönksen P. H. (1994) The glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. 87, 21-29.
35. Menzel E. J. and Reihsner R. (1991) Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymatic glycation and their inhibition by dibasic amino acids arginine and lysine. Diabetoiogia, 43, 12-16.
36. Monnier V. M., Viswanath V., Frank K. E., Elmets C. A., Dauchot P. and Kohn R. R. (1986) Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. New Engl. J. Med. 314, 403-408.
37. Nishimura C., Furue M., Ito T., Ohmori Y. and Tanimoto T. (1993) Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Biochem. Pharmacol. 46, 21-28.
38. Nukaya H., Iwami T., Ishida H., Tsuji K., Suwa Y., Wakabayashi K., Nagao M., Sugimura T. and Kosuge T. (1990) N-2 Acetylation of 2′-deoxyguanosine by coffee mutagens, methylglyoxal and hydrogen peroxide. Mutat. Res. 245, 251-257.
39. Ohmori S., Mori M., Shirahi K. and Kawase M. (1989) Biosynthesis and degradation of methylglyoxal in animals. In: Enzymology and Molecular Biology of Carbonyl Metabolism, pp. 397-412. A. R. Liss, New York.
40. Palkama T. (1991) Induction of interleukin 1 production by ligands binding to the scavenger receptor in human monocytes and the THP-1 cell line. Immunology 74, 432-438.
41. 2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end-product. Biochemistry, 34, 648-655.
42. Phillips S. A. and Thornalley P. J. (1993a) The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Em. J. Biochem. 212, 101-105.
43. Phillips S. A. and Thornalley P. J. (1993b) Formation of methylglyoxal and D-lactate in human red blood cells in vitro. Biochem. Soc. Trans. 21, 163S.
44. Phillips S. A., Mirrlees D. and Thornalley P. J. (1993) Modification of the glyoxalase system in streptozotocin-induced diabetic rats: effect of the aldose reductase inhibitor Statil. Biochem. Pharmacol. 46, 805-811.
45. Pompliano D. L., Peyman A. and Knowles J. R. (1990) Stabilization of a reaction intermediate as a catalytic device: definition of the functional role of the flexible loop in triosephosphate isomerase. Biochemistry, 29, 3186-3194.
46. Praloran R., Le Meur Y., Coupey L. and Rince M. (1995) Increased levels of serum macrophage colony stimulating factor (M-CSF or CSF-1) in patients with chronic renal insufficiency (CRF): facts and hypothesis. Cytokine 7, 221-222.
47. 1NMR and computer model. Eur. J. Biochem. 193, 83-90.
48. Rahman A., Shahabuddin A. and Hadi S. M. (1990) Formation of strand breaks and interstrand cross-links in DNA by methylglyoxal. J. Biochem. Toxicol. 5, 161-166.
49. Rajavashisth T. B., Andalibi A., Territo M. C., Berliner J. C., Navab M., Fogelman A. M. and Lusis A. J. (1990) Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344, 254-257.
50. Ray S. and Ray M. (1981) Isolation of methylglyoxal synthase from goat liver. J. Biol. Chem. 256, 6230-6234.
51. Reichard G. A., Jr., Haff A. C, Skutches C. L., Paul P., Holroyde C. P. and Owen O. E. (1979) Plasma acetone in fasting humans. J. Clin. Invest. 63, 619-626.
52. Reichard G. A., Jr., Skutches C. L., Hoeldtke R. D. and Owen O. E. (1986) Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 35, 668-674.
53. Richard J. P. (1991) Kinetic parameters for the elimination reaction catalyzed by triosephosphate isomerase and an estimation of the reaction's physiological significance. Biochemistry 30, 4581-4585.
54. Roubenoff R. and Rall L. C. (1993) Humoral mediation of changing body-composition during aging and chronic inflammation. Nutrit. Revs. 51, 1-11.
55. Schmidt A. M., Mora R., Cao R., Yan S. D., Brett J., Ramakrishnan R., Tsang T. C., Simionescu M. and Stern D. (1994) The endothelial cell binding site for advanced glycation endproducts consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J. Biol. Chem. 269, 9882-9888.
56. 2-alkylguanines. Biochemistry 8, 238-245.
57. Shaw S. M. and Crabbe M. J. C. (1994a) Monitoring the progress of nonenzymatic glycation in vitro. Int. J. Peptide Protein Res. 44, 594-602.
58. Shaw S. M. and Crabbe M. J. C. (1994b) Nonspecific binding of advanced-glycosylation end-products to macrophages outweighs specific receptor-mediated interactions. Biochem. J. 304, 121-129.
59. Soulis-Liparota T., Cooper M., Parazoglou D., Clarke B. and Jerums G. (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40, 1328-1334.
60. Stewart R. J. and Marsden P. A. (1995) Biologic control of the tumor-necrosis-factor and interleukin-1 signaling cascade. Amer. J. Kidney Diseases 25, 954-966.
61. Takahashi M., Fujii J., Teshima T., Suzuki K., Shiba T. and Taniguchi N. (1993) Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression. Gene 127, 249-253.
62. Taylor R. and Agius L. (1988) The biochemistry of diabetes. Biochem. J. 250, 625-640.
63. Thornalley P. J. (1988) Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem. J. 254, 751-755.
64. Thornalley P. J. (1993) The glyoxalase system in health and disease. Mol. Aspects of Med. 14, 287-371.
65. Thornalley P. J. (1995) Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor. Crit. Revs. Hematol. Oncol. 20, 99-128.
66. Thornalley P. J., Strath M. J. and Wilson R. J. M. (1994) Anti-malarial activity of the glyoxalase I inhibitor diester, S-p-bromobenzylglutathione diethyl ester. Biochem. Pharmacol. 47, 418-420.
67. Thornalley P. J., Edwards L. G., Adesida A. and Double J. (1995) Novel antitumor agents designed from the glyoxalase system. Proc. Amer. Assoc. Cancer Res. 36, 386.
68. Tucker J. D., Taylor R. T., Christensen M. L., Strout C. L., Hanna M. L. and Carrano A. V. (1989) Cytogenetic response to 1,2-dicarbonyls and hydrogen peroxide in Chinese hamster ovary AUXB1 cells and human peripheral lymphocytes. Mutat. Res. 224, 269-279.
69. Ueno H., Segawa T., Hasegawa T., Nakamuro K., Maeda H., Hiramatsu Y., Okada S. and Sayato Y. (1991) Subchronic oral toxicity of glyoxal via drinking water in rats. Fundamental Appld. Toxicol. 16, 763-772.
70. 32P-postlabelling technique for the analysis of 2′-deoxyguanosine-3′-monophosphate and DNA of methylglyoxal. Cardnogenesis 15, 1887-1894.
71. Vander Jagt D. L., Daub F., Krohn J. A., and Han L.-P.B. (1975) Effects of pH and thiols on the kinetics of yeast glyoxalase I. An evaluation of the random pathway mechanism. Biochemistry 14, 3669-3675.
72. Vander Jagt D. L., Hunsaker L. A., Campos N. M. and Baack B. R. (1990) D-Lactate production in erythrocytes infected with Plasmodium falciparum. Mol. Biodiem. Parasitol. 42, 277-284.
73. Vander Jagt D. G., Robinson B., Taylor K. T. and Hunsaker L. A. (1992) Reduction of trioses by NADPH-dependent aldo-keto reductase. J. Biol. Chem. 267, 4364-4369.
74. Vince R. and Wadd W. B. (1969) Glyoxalase inhibitors as potential anticancer agents. Biochem. Biophys. Res. Comm. 35, 593-598.
75. Westwood M. E., McLellan A. C. and Thornalley P.J. (1994) Receptor-mediated endocytic uptake of methylglyoxal-modified protein. Competition with advanced glycation endproduct-modified protein at the advanced glycation endproduct receptor. J. Biol. Chem. 269, 32293-32298.
76. Westwood M. E. and Thornalley P. J. (1995a) Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J. Protein Chem. 4, 359-372.
77. Westwood M. E. and Thornalley P. J. (1995b) Cytokine synthesis and secretion induced by methylglyoxal-modified proteins. Diabetic Med. 12 (suppl. 2-10), 549.